Prelude Therapeutics Inc (PRLD)
3.87
+0.02
(+0.52%)
USD |
NASDAQ |
Apr 23, 16:00
3.90
+0.03
(+0.78%)
After-Hours: 20:00
Prelude Therapeutics Market Cap: 212.54M for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 23, 2024 | 212.54M |
| April 22, 2024 | 211.44M |
| April 19, 2024 | 204.30M |
| April 18, 2024 | 188.93M |
| April 17, 2024 | 229.57M |
| April 16, 2024 | 269.66M |
| April 15, 2024 | 309.20M |
| April 12, 2024 | 308.65M |
| April 11, 2024 | 286.69M |
| April 10, 2024 | 271.86M |
| April 09, 2024 | 274.05M |
| April 08, 2024 | 258.13M |
| April 05, 2024 | 258.13M |
| April 04, 2024 | 260.32M |
| April 03, 2024 | 259.23M |
| April 02, 2024 | 253.73M |
| April 01, 2024 | 257.58M |
| March 28, 2024 | 260.32M |
| March 27, 2024 | 261.97M |
| March 26, 2024 | 253.18M |
| March 25, 2024 | 253.18M |
| March 22, 2024 | 258.13M |
| March 21, 2024 | 264.72M |
| March 20, 2024 | 265.82M |
| March 19, 2024 | 265.82M |
| Date | Value |
|---|---|
| March 18, 2024 | 255.38M |
| March 15, 2024 | 260.32M |
| March 14, 2024 | 244.95M |
| March 13, 2024 | 253.73M |
| March 12, 2024 | 225.17M |
| March 11, 2024 | 224.63M |
| March 08, 2024 | 242.75M |
| March 07, 2024 | 240.55M |
| March 06, 2024 | 229.02M |
| March 05, 2024 | 227.92M |
| March 04, 2024 | 233.41M |
| March 01, 2024 | 252.09M |
| February 29, 2024 | 236.16M |
| February 28, 2024 | 229.02M |
| February 27, 2024 | 230.12M |
| February 26, 2024 | 224.63M |
| February 23, 2024 | 217.49M |
| February 22, 2024 | 212.54M |
| February 21, 2024 | 207.60M |
| February 20, 2024 | 228.47M |
| February 16, 2024 | 254.28M |
| February 15, 2024 | 191.12M |
| February 14, 2024 | 185.63M |
| February 13, 2024 | 171.35M |
| February 12, 2024 | 176.84M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
92.66M
Minimum
Oct 31 2023
4.270B
Maximum
Feb 10 2021
826.30M
Average
327.66M
Median
Sep 19 2022
Market Cap Benchmarks
| CEL-SCI Corp | 79.35M |
| AIM ImmunoTech Inc | 21.23M |
| IGC Pharma Inc | 29.10M |
| NovaBay Pharmaceuticals Inc | 2.318M |
| Protalix BioTherapeutics Inc | 87.66M |
Market Cap Related Metrics
| Price to Book Value | 0.8965 |
| Price | 3.87 |
| Earnings Yield | -52.71% |